Sort
64,565 grants matching “drug discovery”
Genome Sequencing of Toxoplasma gondii
$1,326,536Institute For Genomic Research · U01 · FY2002 · AI
Preclinical Development of HIV-1 Vif Antagonists
$1,326,345Mario Stevenson · Univ Of Massachusetts Med Sch Worcester · U19 · FY2008 · MH
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,326,006Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2012 · HL
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,326,006Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2011 · HL
Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center
$1,326,000Mustafa None Sahin · Boston Children'S Hospital · P50 · FY2021 · HD
Safety and tolerability testing of VU0467319: an M1 PAM for clinical development
$1,325,033Craig Lindsley · Vanderbilt University · U19 · FY2017 · MH
Purchase of a 700MHz NMR Spectrometer for Liquid Applications
$1,324,730John Montgomery · University Of Michigan At Ann Arbor · S10 · FY2009 · RR
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery
$1,324,494Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI
The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development
$1,324,424Leslie Michels Thompson · University Of California-Irvine · U24 · FY2012 · NS
Molecular Genetics of Inherited Neurological Diseases
$1,324,410Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2009 · NS
NINDS Human Cell and Data Repository (U24)
$1,323,650Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2023 · NS
SBIR Phase II: Semantic Link Association Prediction for Phenotypic Drug Discovery
$1,323,521Robin McEntire · Data2discovery Inc · · FY2017 · TIP
Discovery of Novel Drugs for Alzheimer's Disease
$1,323,404James W. Simpkins · University Of North Texas Hlth Sci Ctr · P01 · FY2008 · AG
Chemoprevention of Skin Cancer Program Project
$1,323,325David S Alberts · University Of Arizona · P01 · FY2012 · CA
Lead optimization and development of novel targeted small molecule therapeutics for Alzheimers disease
$1,322,759Satheesh B Ravula · Epigen Biosciences, Inc. · R44 · FY2020 · AG
Role of CEBP transcription factors in regulating cell growth and tumorigenesis
$1,321,912Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
NINDS Human Cell and Data Repository (U24)
$1,321,623Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2020 · NS
Discovery to Implementation & Back: Research Translation for the HIV/SU Epidemic
$1,321,292Sherry Deren · New York University · P30 · FY2013 · DA
Screening for a Drug for Sickle Cell Disease
$1,320,868William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Targeting cell-type specific disease phenotypes to promote CNS repair
$1,320,578Jae K Lee · University Of Miami School Of Medicine · RM1 · FY2023 · NS
Novel Antiangiogenic Peptides for Treatment of Exudative AMD
$1,320,393Nader Sheibani · University Of Wisconsin-Madison · R24 · FY2016 · EY
RTG: Computational Mathematics for Data Science
$1,320,195James G Nagy · Emory University · · FY2021 · MPS
UC San Diego Clinical and Translational Research Institute
$1,320,077Colin A Depp · University Of California, San Diego · KL2 · FY2015 · TR
SPIGELMAN (UCLA) - MCSP- EXPLORATORY CHEMISTRY (EC)
$1,319,807Matthew Surman · Albany Molecular Research, Inc. · N01 · FY2024 · DA
Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)
$1,319,759Kenneth W Turteltaub · University Of Calif-Lawrnc Lvrmr Nat Lab · P41 · FY2015 · GM